Paula J Lum

发表

Clinical presentation and course of acute hepatitis C infection in HIV-infected patients.

C. B. Hare, D. Havlir, P. Tien, 2006, Journal of acquired immune deficiency syndromes.

Assessing Candidacy for Acute Hepatitis C Treatment Among Active Young Injection Drug Users: A Case‐Series Report

K. Page, P. Lum, A. Asher, 2012, The Journal of the Association of Nurses in AIDS Care : JANAC.

Continued Transmission of HIV Among Young Adults Who Inject Drugs in San Francisco: Still Room for Improvement

A. Mirzazadeh, S. Shiboski, M. Busch, 2018, AIDS and Behavior.

Changes in Specific Substance Involvement Scores among SBIRT recipients in an HIV primary care setting

C. Dawson-Rose, Y. Cuca, B. Cooper, 2017, Addiction Science & Clinical Practice.

Higher risk of incident hepatitis C virus among young women who inject drugs compared with young men in association with sexual relationships: a prospective analysis from the UFO Study cohort

J. Hahn, Jennifer L Evans, A. Briceño, 2014, BMJ Open.

Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users.

J. Hahn, K. Page, J. Tsui, 2014, JAMA internal medicine.

Comorbid substance use among persons with HIV and chronic pain

R. D. Bruce, P. Lum, Paula J Lum, 2016 .

Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection.

L. Avanesyan, E. Delwart, S. Shiboski, 2009, The Journal of infectious diseases.

A Delayed Injection-Site Reaction in A Patient Receiving Extended-Release Naltrexone

P. Korthuis, P. Lum, K. Ahamad, 2016, Substance abuse.

Rationale and design of a randomized pragmatic trial of patient-centered models of hepatitis C treatment for people who inject drugs: The HERO study.

M. Heo, L. Taylor, A. Karasz, 2019, Contemporary clinical trials.

2017 HIVMA of IDSA Clinical Practice Guideline for the Management of Chronic Pain in Patients Living With HIV.

R. D. Bruce, K. Foley, P. Selwyn, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Investigation of a Secondary Syringe Exchange Program for Homeless Young Adult Injection Drug Users in San Francisco, California, U.S.A.

J. Guydish, E. Weltzien, P. Lum, 2001, Journal of acquired immune deficiency syndromes.

Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO study)

A. Moss, J. Hahn, K. Page-Shafer, 2003, Journal of Urban Health.

Smoking cessation interventions with female smokers living with HIV/AIDS: A randomized pilot study of motivational interviewing

J. K. Manuel, J. Sorensen, P. Lum, 2013, AIDS care.

Dismantling racism against Black, Indigenous, and people of color across the substance use continuum: A position statement of the association for multidisciplinary education and research in substance use and addiction

S. Levy, A. Gordon, Jeffrey P. Bratberg, 2021, Substance abuse.

Predictors of injection drug use cessation and relapse in a prospective cohort of young injection drug users in San Francisco, CA (UFO Study).

J. Hahn, K. Page, P. Lum, 2009, Drug and alcohol dependence.

Interaction of disulfiram with antiretroviral medications: efavirenz increases while atazanavir decreases disulfiram effect on enzymes of alcohol metabolism.

M. D. Faiman, P. Wallace, V. Gruber, 2014, The American journal on addictions.

Higher risk of incident hepatitis C virus among young women who inject drugs compared with young men in association with sexual relationships: a prospective analysis from the UFO Study cohort

J. Hahn, A. Briceño, K. Page, 2014, BMJ Open.

Preventing hepatitis C virus infection in injection drug users: risk reduction is not enough.

J. Hahn, K. Page-Shafer, P. Lum, 2007, AIDS.

Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco

A. Moss, J. Hahn, K. Page-Shafer, 2001, Hepatology.

Addressing Adolescent Substance Use: Teaching Screening, Brief Intervention, and Referral to Treatment (Sbirt) and Motivational Interviewing (Mi) to Residents

Jason M. Satterfield, Amy Whittle, P. O’Sullivan, 2015, Substance abuse.

Opioid-Prescribing Practices and Provider Confidence Recognizing Opioid Analgesic Abuse in HIV Primary Care Settings

J. Mitty, D. Fiellin, J. Egan, 2011, Journal of acquired immune deficiency syndromes.

The medical management of opioid dependence in HIV primary care settings

J. Tulsky, P. Lum, Paula J Lum, 2006, Current HIV/AIDS reports.

Perspectives on extended-release naltrexone induction among patients living with HIV and opioid use disorder: a qualitative analysis

P. Korthuis, D. McCarty, L. Fanucchi, 2021, Addiction Science & Clinical Practice.

Barriers and facilitators to recruitment and enrollment of HIV-infected individuals with opioid use disorder in a clinical trial

Kim A. Hoffman, P. Korthuis, D. McCarty, 2019, BMC Health Services Research.

Drug Treatment Outcomes Among HIV-Infected Opioid-Dependent Patients Receiving Buprenorphine/Naloxone

F. Altice, P. O'Connor, R. Schottenfeld, 2011, Journal of acquired immune deficiency syndromes.

The Impact of Cocaine Use on Outcomes in HIV-Infected Patients Receiving Buprenorphine/Naloxone

J. Mitty, P. O'Connor, R. Schottenfeld, 2011, Journal of acquired immune deficiency syndromes.

HIV clinic‐based extended‐release naltrexone versus treatment as usual for people with HIV and opioid use disorder: a non‐blinded, randomized non‐inferiority trial

Kim A. Hoffman, D. McCarty, Elizabeth H. Payne, 2022, Addiction.

HIV Treatment Outcomes Among HIV-Infected, Opioid-Dependent Patients Receiving Buprenorphine/Naloxone Treatment within HIV Clinical Care Settings: Results From a Multisite Study

R. D. Bruce, F. Altice, P. Korthuis, 2011, Journal of acquired immune deficiency syndromes.

Using Interactive Web-Based Screening, Brief Intervention and Referral to Treatment in an Urban, Safety-Net HIV Clinic

Emiko Kamitani, Y. Cuca, Jessica E. Draughon, 2015, AIDS and Behavior.

Commercial Sex Work and Risk of HIV Infection Among Young Drug-Injecting Men Who Have Sex With Men in San Francisco

A. Moss, J. Hahn, K. Page-Shafer, 2006, Sexually transmitted diseases.

Associations between fentanyl use and initiation, persistence, and retention on medications for opioid use disorder among people living with uncontrolled HIV disease.

P. Korthuis, L. Fanucchi, G. Lucas, 2021, Drug and alcohol dependence.

Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection.

Michael R. Wierzbicki, A. Folgori, A. Nicosia, 2021, The New England journal of medicine.

Low barrier buprenorphine treatment for persons experiencing homelessness and injecting heroin in San Francisco

P. Lum, B. Zevin, Jamie Carter, 2019, Addiction Science & Clinical Practice.

Untreated HIV Infection Is Associated With Higher Blood Alcohol Levels

V. Gruber, M. Peters, E. McCance-Katz, 2012, Journal of acquired immune deficiency syndromes.

Interactions between Alcohol and the HIV Entry Inhibitor Maraviroc

V. Gruber, F. Aweeka, E. McCance-Katz, 2013, Journal of the International Association of Providers of AIDS Care.

Interactions Between Alcohol and the Antiretroviral Medications Ritonavir or Efavirenz

V. Gruber, E. McCance-Katz, P. Lum, 2013, Journal of addiction medicine.

Hepatitis C virus risk behaviors within the partnerships of young injecting drug users.

J. Hahn, P. Davidson, P. Lum, 2010, Addiction.

Computer-Facilitated 5A's for Smoking Cessation: A Randomized Trial of Technology to Promote Provider Adherence.

Jason M. Satterfield, S. Gregorich, R. Muñoz, 2018, American journal of preventive medicine.

2017 HIVMA of IDSA Clinical Practice Guideline for the Management of Chronic Pain in Patients Living With HIV.

R. D. Bruce, K. Foley, P. Selwyn, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Beyond the Ask and Advise: Implementation of a Computer Tablet Intervention to Enhance Provider Adherence to the 5As for Smoking Cessation.

Jason M. Satterfield, S. Gregorich, R. Muñoz, 2016, Journal of substance abuse treatment.

Traveling young injection drug users at high risk for acquisition and transmission of viral infections.

J. Hahn, K. Page-Shafer, P. Lum, 2008, Drug and Alcohol Dependence.

Hepatitis B virus immunization among young injection drug users in San Francisco, Calif: the UFO Study.

A. Moss, J. Hahn, Jennifer L Evans, 2003, American journal of public health.

Hepatitis C virus seroconversion among young injection drug users: relationships and risks.

M. Busch, A. Moss, J. Hahn, 2002, The Journal of infectious diseases.

Prevalence and Correlates of HIV Infection Among Young Injection Drug Users in San Francisco

A. Moss, J. Hahn, P. Lum, 2002, Journal of acquired immune deficiency syndromes.

Opioids, Hepatitis C Virus Infection, and the Missing Vaccine.

K. Page, P. Lum, A. Cox, 2018, American journal of public health.

HIV vaccine trial willingness among injection and non-injection drug users in two urban centres, Barcelona and San Francisco.

J. Gatell, K. Page, P. Lum, 2011, Vaccine.

Mortality among young injection drug users in San Francisco: a 10-year follow-up of the UFO study.

J. Hahn, Jennifer L Evans, K. Page, 2012, American journal of epidemiology.

Integrated HIV care is associated with improved engagement in treatment in an urban methadone clinic

P. Lum, C. Simeone, Brad J Shapiro, 2017, Addiction Science & Clinical Practice.

A Skills-Based Curriculum for Teaching Motivational Interviewing-Enhanced Screening, Brief Intervention, and Referral to Treatment (SBIRT) to Medical Residents

N. Ratanawongsa, Jennifer E. Hettema, Soraya Azari, 2015 .

Hepatitis B virus infection and immunization status in a new generation of injection drug users in San Francisco

A. Moss, J. Hahn, P. Davidson, 2007, Journal of viral hepatitis.

Disparities in receipt of 5As for smoking cessation in diverse primary care and HIV clinics

Jason M. Satterfield, S. Gregorich, S. Kalkhoran, 2017, Preventive medicine reports.

Temporal changes in HCV genotype distribution in three different high risk populations in San Francisco, California

E. Delwart, M. Busch, S. Deeks, 2011, BMC infectious diseases.

Prevalence and predictors of HCV among a cohort of opioid treatment patients in Dar es Salaam, Tanzania.

B. Lambdin, J. Mbwambo, A. Kral, 2017, The International journal on drug policy.

Ethnically Diverse Patients’ Perceptions of Clinician Computer Use in a Safety-net Clinic

Jennifer L. Barton, Dean Schillinger, Edward H. Yelin, 2013, Journal of health care for the poor and underserved.

A SBIRT Curriculum for Medical Residents: Development of a Performance Feedback Tool to Build Learner Confidence

N. Ratanawongsa, Jennifer E. Hettema, D. Ciccarone, 2012, Substance abuse.

Feasibility and safety of extended‐release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: a pilot/feasibility randomized trial

P. Korthuis, R. Mandler, R. Lindblad, 2017, Addiction.

Frequent methamphetamine use is associated with primary non-nucleoside reverse transcriptase inhibitor resistance

E. Vittinghoff, F. Hecht, R. Grant, 2007, AIDS.